Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neurocrine ( (NBIX) ) has shared an update.
Neurocrine Biosciences has appointed Dr. Kyle Gano as their new President and CEO starting October 11, 2024, with a generous compensation package including a $900,000 annual salary, potential 100% bonus, and varied equity grants totaling approximately $1.5 million, which vest over four years. Dr. Gano’s contract also outlines substantial severance benefits in the event of involuntary termination, with specifics dependent on the timing and context of his departure, including potential accelerated equity award vesting and health plan coverage.
Learn more about NBIX stock on TipRanks’ Stock Analysis page.